Navigation Links
Amsterdam Molecular Therapeutics Announces Negative Equity Position
Date:12/14/2011

AMSTERDAM, December 15, 2011 /PRNewswire/ --

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the Company has a negative equity position, as a result of ongoing loss-making operations. The development of this negative equity position is in line with previous guidance that the Company has cash into early 2012, and is exploring alternatives for additional financing.

AMT announced on November 17, 2011 that its cash position at September 30, 2011 amounted to € 3.8 million, and AMT continues to be loss making and to experience net cash outflows. At December 12, 2011 AMT's cash position amounted to € 2.1 million; AMT does not have any loan, credit or other borrowing facilities other than the € 5 million convertible loan issued in December 2009.

The Company continues partnering discussions with pharma companies. At this time, AMT anticipates that it may be possible to conclude a partnership for its hemophilia B program during the first half of 2012, provided that additional funding can be secured in the meantime. AMT is also looking at additional collaborations with academic groups, which would contribute towards the short-term funding of its GDNF program for up to three indications.

AMT is continuing to explore all options with regard to the business, its financing, and support from existing shareholders. This includes selling all or part of the business, and raising additional capital in conjunction with its bankers and investors. AMT is also tracking opportunities for funding, from non-dilutive sources such as grants, and collaborations with partners. The Company has already taken appropriate action to reduce its costs, and the number of employees has decreased by approximately 50 per cent to 45 staff. Further cost reductions are possible but the savings would not provide a significantly longer runway for seeking a funding solution. Additional reductions m
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
2. Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline
3. Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application
4. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
5. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
6. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
7. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
8. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
9. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
10. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
11. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . ... have demonstrated a new kind of building block for ... chips could be based on three-dimensional arrangements of nanometer-scale ... of the semiconductor industry CMOS fabrication of silicon ... collaborators at the University of Notre Dame are exploring ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... - 2014 Summary Global Markets Direct,s, ... - 2014, provides an overview of the Pacific ... This report provides comprehensive information on the ... LLC,s, complete with comparative analysis at various stages, ...
(Date:9/30/2014)... Shimadzu Scientific Instruments has released the DSES-1000 long-travel ... for measuring displacement in rubber and other soft ... distance, the DSES-1000 can measure elongations up to ... mm. In addition, it achieves +/- 0.2 percent ... +/- 100 µm below 50-mm stroke. , The ...
(Date:9/30/2014)... 30, 2014 Over the last decade, ... to rising R&D budgets and increased acceptance of new ... pharmaceutical and biotechnology industries are also catalyzing the growth ... market is expected to grow at a strong CAGR ... to be worth $2,532.6 million by 2019. The market ...
Breaking Biology Technology:A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5
... Nov. 29, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., has received approval from the United States ... Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ... contraceptive product.  Watson is currently involved in patent litigation ...
... a leading manufacturer of antibodies and ... will be launching a new line of antibodies ... are key players in spindle assembly. ... http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b ) Hice1 is a ...
... from Rensselaer Polytechnic Institute demonstrates how graphene foam can ... and explosive chemicals. The discovery opens the door for ... by bomb squads, law enforcement officials, defense organizations, and ... and repeatedly measured ammonia (NH3) and nitrogen dioxide (NO2) ...
Cached Biology Technology:Watson's Generic Yaz(R) Receives FDA Approval 2GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 2GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 3Graphene foam detects explosives, emissions better than today's gas sensors 2Graphene foam detects explosives, emissions better than today's gas sensors 3Graphene foam detects explosives, emissions better than today's gas sensors 4Graphene foam detects explosives, emissions better than today's gas sensors 5
(Date:9/30/2014)... some hope: A new research report published in October ... , explains how scientists developed a synthetic version of ... development in human and mouse eggs similar to the ... during fertilization. , "We believe that the results of ... understanding of human fertilization by providing a precise answer ...
(Date:9/30/2014)... suite of perilous threats in today,s ocean. From ... change, fragile coral ecosystems are disappearing at unprecedented ... species of corals surrounding the island of Moorea ... their tropical environment: coral guard-crabs. New research from ... Station scientist Seabird McKeon and the museum,s predoctoral ...
(Date:9/29/2014)... called Clostridium ramosum , coupled with a high-fat diet, ... this week in mBio , the online open-access journal ... team from the German Institute of Human Nutrition Potsdam-Rehbruecke in ... C. ramosum gained weight when fed a high-fat diet. ... less obese even when consuming a high-fat diet, and mice ...
Breaking Biology News(10 mins):Synthetic sperm protein raises the chance for successful in vitro fertilization 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Gut bacteria promote obesity in mice 2
... History and geology, not current ecology, are likely what ... site, according to a new study published in the ... associate at the Smithsonian Tropical Research Institute in Panama. ... worldwide. The difference is that tropical organisms have been ...
... 23, 2011 Two Arizona university graduate students working ... received $50,000 grants from the Salt River Project (SRP). ... Pathogen Genomics Division in Flagstaff, and Brooke Hjelm, a ... each the recipients of $50,000 awards from SRP,s Arizona ...
... Females in inbred populations become more promiscuous in order to ... study by the University of East Anglia (UEA). ... help answer the puzzling evolutionary question of why females in ... single male can provide full fertility and promiscuity can carry ...
Cached Biology News:What makes rainforests unique? History, not ecology 2TGen graduate students receive $50,000 each from Salt River Project's support program 2Female promiscuity can rescue populations from harmful effects of inbreeding 2Female promiscuity can rescue populations from harmful effects of inbreeding 3
Alexa Fluor 350/488/594 Filter Set (Semrock Brightline) *mounted* *Zeiss Axio AF...
...
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
Request Info...
Biology Products: